Roche Holding | ROG - Ebitda




Roche Holding reported CHF12.68B in EBITDA for its fiscal semester ending in June of 2024.

Ebitda Change Date
AbbVie USD 6.03B 1.03B Sep/2024
Alcon AG USD 647M 6M Sep/2024
Almirall EUR 84.69M 66.19M Jun/2024
Amgen USD 2.93B 517M Dec/2024
AstraZeneca USD 5.26B 597M Dec/2024
Bayer EUR 5.03B 3.3B Sep/2024
Biogen USD 535.5M 226.5M Dec/2024
Bristol-Myers Squibb USD 4.73B 48M Dec/2024
Eli Lilly USD 4.9B 786M Sep/2024
Fresenius EUR 822M 235M Sep/2024
Fresenius Medical Care EUR 811M 19M Sep/2024
Galapagos EUR -48446000 52.4M Sep/2024
Genmab DKK 2.23B 85M Sep/2024
Gilead Sciences USD 3.1B 661M Dec/2024
GlaxoSmithKline GBP 2.08B 1.22B Dec/2024
GRIFOLS EUR 450.73M 109.22M Sep/2024
Hikma Pharmaceutical USD 453M 98M Jun/2024
Lonza CHF 873M 107M Jun/2024
Merck EUR 1.62B 85M Sep/2024
Merck USD 6.07B 1.38B Sep/2024
Novartis USD 5.19B 319M Dec/2024
Orion EUR 227.5M 161.7M Sep/2024
Pfizer USD 4.26B 2.59B Dec/2024
Philips EUR 945M 594M Dec/2024
Recordati EUR 216.96M 25.45M Sep/2024
Regeneron Pharmaceuticals USD 1.06B 572.8M Dec/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.25B 2.22B Sep/2024
UCB EUR 652M 105M Jun/2024